168 participants
A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-06-24
- Start Date:
- 2009-07-16
- Completion:
- 2016-11-15
Conditions
- Extensive Stage Small Cell Lung Carcinoma
- Recurrent Small Cell Lung Carcinoma
Interventions
- DRUG
- BIOLOGICAL
- OTHER